Literature DB >> 34550542

Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome.

Xiaobo Fang1,2, Yanling Liang1, Weixi Zhang3, Qiong Wang1, Jingsi Chen2, Jia Chen1, Yongqiang Lin1, Yanli Chen1, Li Yu2, Haibin Wang4, Dunjin Chen5.   

Abstract

Obstetric posterior reversible encephalopathy syndrome (PRES), caused by preeclampsia (PE) or eclampsia, is a clinical imaging syndrome and a critical maternal complication, with vasogenic edema in white matter as a typical imaging characteristic. Serum neurofilament light (NFL) is a marker of neuroaxonal injury. Therefore, we performed this study to explore the diagnostic and prognostic role of NFL in obstetric PRES. We used stored serum samples and clinical data obtained from 2148 PE or eclampsia patients from the Guangzhou Medical Centre for Critical Pregnant Women from January 2015 to January 2020. The serum NFL concentration was measured by Simoa assay. Patients without complete data and MRI examinations were excluded. All patients were grouped into the PRES and non-PRES groups based on the PRES diagnostic criteria. In total, 222 patients met the inclusion criteria and were grouped into the PRES (n = 123) and non-PRES (n = 99) groups. The NFL level was significantly higher in the PRES group than in the non-PRES group (p < 0.0001). The discriminatory accuracy of diagnostic panels (headaches + NFL, NFL) in receiver operating characteristic curve analysis (area under the curve) was 0.9338 and 0.7664. Importantly, the NFL level was significantly correlated with edema severity (Spearman's correlation, p < 0.0001), and a poorer pregnancy outcome was observed in the PRES group. In conclusion, an increased NFL level can add predictive value for diagnosing obstetric PRES, and its level is associated with both clinical severity and pregnancy outcome, suggesting that NFL could serve as a diagnostic and prognostic biomarker for obstetric PRES.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Eclampsia; Neurofilament light; Posterior reversible encephalopathy syndrome; Seizure

Mesh:

Substances:

Year:  2021        PMID: 34550542     DOI: 10.1007/s12035-021-02562-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  32 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia.

Authors:  Gerda G Zeeman; F Gary Cunningham
Journal:  Am J Obstet Gynecol       Date:  2013-11-18       Impact factor: 8.661

4.  Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Authors:  Lars Neeb; Jenneke Hoekstra; Matthias Endres; Bob Siegerink; Eberhard Siebert; Thomas G Liman
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

5.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

6.  A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia.

Authors:  Xiaobo Fang; Yanling Liang; Dunjin Chen; Fang He; Jia Chen; Fami Huang
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

Review 7.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

Review 8.  Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?

Authors:  Bo Gao; Cui Lyu; Alexander Lerner; Alexander M McKinney
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-09       Impact factor: 10.154

9.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

Review 10.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

View more
  1 in total

1.  Maternal and Perinatal Outcome of Posterior Reversible Encephalopathy Syndrome (PRES) in Patients with Eclampsia at Tertiary Health Care Centre.

Authors:  Varsha Deshmukh; Vikas R Gangurde; Shrineewas Gadappa
Journal:  J Obstet Gynaecol India       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.